home / stock / asnd / asnd short
Twenty Trading Day Totals | |
---|---|
Total Shorted Volume | 3,073,651 |
Total Actual Volume | 8,464,713 |
Short Trends | |
---|---|
Cover Days | 0 |
Short Days | 19 |
No Change Days | 1 |
Averages | |
---|---|
Average Short Volume | 153,683 |
Average Short Percentage | 70.74% |
Is there a ASND Short Squeeze or Breakout about to happen?
See the ASND Short Analysis for free Sign up or Login
Powered by Squeeze Report
Stock Date | Open Price | Close Price | High | Low | Total Volume | Short Volume | Short Percentage |
---|---|---|---|---|---|---|---|
2022-08-09 | 98.36 | 89.28 | 98.79 | 92.79 | 624,810 | 339,477 | 83.7611 |
2022-08-08 | 95.28 | 89.28 | 100.04 | 94.96 | 1,414,129 | 503,081 | 79.1639 |
2022-08-05 | 90.07 | 89.28 | 95.29 | 88.9 | 1,149,457 | 451,186 | 80.3051 |
2022-08-04 | 89.49 | 89.28 | 92.77 | 89.05 | 496,289 | 183,545 | 78.0903 |
2022-08-03 | 86.96 | 89.28 | 89.98 | 86.825 | 197,894 | 54,696 | 69.5710 |
2022-08-02 | 83.92 | 89.28 | 87.71 | 83.92 | 320,159 | 115,135 | 85.2460 |
2022-08-01 | 85.08 | 89.28 | 87.11 | 83.61 | 164,796 | 46,768 | 75.2284 |
2022-07-29 | 86.29 | 89.28 | 87.88 | 84.8375 | 239,427 | 56,430 | 57.5276 |
2022-07-28 | 89.28 | 89.28 | 89.98 | 85.25 | 207,575 | 33,054 | 40.4108 |
2022-07-26 | 86.3 | 86.3 | 87.64 | 85.05 | 161,807 | 165,609 | 93.1680 |
2022-07-25 | 89.07 | 87.02 | 89.07 | 85.1 | 303,472 | 70,103 | 63.0083 |
2022-07-19 | 87.18 | 87.94 | 88.02 | 85.5 | 157,682 | 34,001 | 61.1100 |
2022-07-18 | 85.86 | 85.5 | 88.57 | 85.17 | 684,301 | 300,349 | 81.0204 |
2022-07-15 | 86.34 | 85.33 | 86.34 | 82.7 | 863,324 | 369,674 | 79.7605 |
2022-07-14 | 87.48 | 85.57 | 88.32 | 85.21 | 162,803 | 44,297 | 57.0749 |
2022-07-13 | 89.33 | 88.57 | 92.42 | 87.76 | 319,532 | 68,854 | 65.4493 |
2022-07-12 | 91.28 | 90.06 | 92.65 | 87.705 | 265,961 | 91,853 | 80.9399 |
2022-07-11 | 93.22 | 90.77 | 93.22 | 90.52 | 241,055 | 51,002 | 73.6310 |
2022-07-06 | 95.49 | 89.5 | 95.8 | 88.76 | 347,356 | 68,443 | 56.4832 |
2022-07-05 | 91.46 | 95.39 | 95.72 | 91.15 | 142,884 | 26,094 | 53.7943 |
News, Short Squeeze, Breakout and More Instantly...
— U.S. regulatory submission for TransCon PTH, designed to be the first parathyroid hormone replacement therapy, on track for Q3 2022; EU submission planned for Q4 2022 — SKYTROFA revenue continued to double quarter-to-quarter, reaching Ȋ...
COPENHAGEN, Denmark, Aug. 04, 2022 (GLOBE NEWSWIRE) -- Ascendis Pharma A/S (Nasdaq: ASND) announced today that the company will hold a conference call and live webcast on Wednesday, August 10, 2022, at 4:30 p.m. Eastern Time (ET) to review its second quarter 2022 financial results and provi...
– Late-breaker oral presentation of TransCon PTH Phase 3 PaTHway Trial data in adult hypoparathyroidism on Tuesday, June 14 – Oral presentation of TransCon PTH Phase 2 PaTH Forward Trial Open-Label Extension Data in adult hypoparathyroidism on ...